Drug Development Insights: What New Industry Data Reveals for 2026
Explore key findings from the 2026 Pulse report and how industry leaders are adapting strategies to navigate uncertainty, manage risk and drive innovation in drug development.
The future for drug developers is increasingly shaped by how effectively they adapt to complexity, change and rising pressure across the development landscape.
To understand how the industry is responding, the PPD™ clinical research business of Thermo Fisher Scientific surveyed 150 leaders at biotech and pharmaceutical organizations worldwide for the fourth annual Pulse industry report. This year’s findings reveal a clear throughline: uncertainty is shaping decisions across R&D, from strategy and investment to execution.
In this webinar, industry experts will explore key signals from the 2026 Pulse research and discuss what they mean for navigating today’s evolving environment. Attendees will gain perspective on how peers are adapting their approaches to remain agile, manage risk and continue advancing innovation.